University of California - Davis Medical Center
Sacramento, California, United States
Health center in Sacramento, California
2315 Stockton Blvd, Sacramento, CA 95817
625 Beds
About University of California - Davis Medical Center
UC Davis Medical Center is part of UC Davis Health and a major academic health center located in Sacramento, California. It is owned and operated by the University of California as part of its University of California, Davis campus.
There are 625 beds in University of California - Davis Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of California, Davis
148
SWOG Cancer Research Network
39
Pfizer
24
Gilead Sciences
21
Children's Oncology Group
18
United Therapeutics
18
National Institute of Allergy and Infectious Diseases (NIAID)
17
Bristol-Myers Squibb
14
Boston Scientific Corporation
13
Abbott Medical Devices
12
Celgene
9
Clinical Trials at University of California - Davis Medical Center
During the past decade, University of California - Davis Medical Center conducted 327 clinical trials. In the 10-year time frame, 327 clinical trials started and 199 clinical trials were completed, i.e. on
average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 111 clinical trials were completed. i.e. 102.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
1989-07-01
Completed
16
(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Completed
600
A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
Completed
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
Completed
140
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
1994-01-01
1995-03-01
Completed
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
Completed
3,000
A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS
Completed
200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of California - Davis Medical Center" #1 sponsor was "University of California, Davis" with 148 trials, followed by "SWOG Cancer Research Network" with 39 trials
sponsored, "Pfizer" with 24 trials sponsored, "Gilead Sciences" with 21 trials sponsored and "Children's Oncology Group"
with 21 trials sponsored. Other sponsors include 461 different institutions and
companies that sponsored additional 255 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of California - Davis Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 18 trials as a collaborator, "University of California, Davis" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Medical University of South Carolina" with 9 trials as a collaborator. Other collaborators include 349 different institutions and companies that were
collaborators in the rest 248 trials.
Clinical Trials Conditions at University of California - Davis Medical Center
According to Clinical.Site data, the most researched conditions in "University of California - Davis Medical Center" are
"HIV Infections" (29 trials), "Duchenne Muscular Dystrophy" (17 trials), "Pulmonary Arterial Hypertension" (17 trials), "Pulmonary Hypertension" (15 trials) and "Lymphoma" (14 trials). Many other conditions were trialed in "University of California - Davis Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at University of California - Davis Medical Center
Most popular intervention types in "University of California - Davis Medical Center" are "Drug" (427 trials), "Device" (107 trials), "Biological" (79 trials), "Other" (69 trials) and "Procedure" (51 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (118 trials), "etoposide" (17 trials), "filgrastim" (17 trials), "cyclophosphamide" (16 trials) and "radiation therapy" (15 trials). Other intervention names were less common.
Clinical Trials Genders at University of California - Davis Medical Center
The vast majority of trials in "University of California - Davis Medical Center" are
637 trials for "All" genders, 40 trials for "Male" genders and 39 trials for "Female" genders.
Clinical Trials Status at University of California - Davis Medical Center
Currently, there are 164 active trials in "University of California - Davis Medical Center".
3 are not yet recruiting,
103 are recruiting,
53 are Active, not recruiting,
and 5 are Enrolling by invitation.
In total, there were 422 completed trials in University of California - Davis Medical Center,
undefined suspended trials,
and 98 terminated clinical trials to date.
Out of the total trials that were conducted in University of California - Davis Medical Center, 60 "Phase 1"
clinical trials were conducted, 207 "Phase 2" clinical
trials and 223 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 32 trials, and there were
also 138 trials that are defined as “Not Applicable".